RENAL MEDULLARY CARCINOMA
Clinical trials for RENAL MEDULLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RENAL MEDULLARY CARCINOMA trials appear
Sign up with your email to follow new studies for RENAL MEDULLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo offers hope for rare genitourinary cancers
Disease control Recruiting nowThis study tests whether two approved cancer drugs, sacituzumab govitecan and atezolizumab, can shrink or control rare tumors of the bladder, kidney, ureters, and penis. About 60 adults with these uncommon cancers will receive the drugs through an IV, either alone or together. Th…
Matched conditions: RENAL MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New drug combo targets rare, tough kidney cancers
Disease control Recruiting nowThis study tests a combination of two drugs, pembrolizumab and enfortumab vedotin, for people with rare and aggressive kidney cancers (collecting duct carcinoma and renal medullary carcinoma). About 23 adults with advanced or metastatic disease will receive the treatment for seve…
Matched conditions: RENAL MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: Giuseppe Procopio • Aim: Disease control
Last updated May 06, 2026 16:03 UTC